This is an artist’s representation of MetaFast work process.
CREDIT
Author Alla Tyakht
Scientists from ITMO University, the Federal Research and Clinical Centre of Physical-Chemical Medicine and MIPT have developed a software program enabling them to quickly compare sets of DNA of microorganisms living in different environments. The researchers have already suggested exactly how the new program could be applied in practice. Using the algorithm to compare the microflora of a healthy person with the microflora of a patient, specialists would be able to detect previously unknown pathogens and their strains, which can aid the development of personalized medicine.
The results of the study have been published in Bioinformatics.
Every person has a genome – a specific sequence of genes according to which an individual develops. However, any living organism contains another gene sequence that is called the metagenome.It is the total DNA content of the many different microorganisms that inhabit the same environment – bacteria, fungi, and viruses. The metagenome is often indicative of various diseases or predispositions to such diseases. Studying microbiota, i.e. the full range of microorganisms inhabiting different parts of the human body, has thereforea criticalrole in metagenomic research.
The software tool developed by the scientists and called MetaFast is able to conduct a rapid comparative analysis of large amounts of metagenomes. “In studying the intestinal microflora of patients, we may be able to detect microorganisms associated with a particular disease, such as diabetes, or a predisposition to the disease. This already forms a basis for applying personalized medicine techniques and developing new drugs. Using the results obtained with the software, biologists will be able to draw conclusions on how to further develop their research, because the algorithm enables them to study environments that we currently know nothing about,” says Vladimir Ulyantsev, lead developer of the algorithm and researcher at the Computer Technologies Laboratory at ITMO University.
One of the key benefits of the program is that it is able to work successfully with environments in which the genetic contents have not yet been studied. “The newly developed approach allows us to do two things – find all the possible gene sequences, even if they were previously unknown (the program collects them from fragments of genomic reads), and at the same time identify metagenomic patterns that distinguish one patient from another, e.g. people with and without a disease,” says Dmitry Alexeev, the leader of the project and head of MIPT’s Laboratory of Complex Biological Systems.
This means that the program can be used to conduct an untargeted express analysis of markers indicating certain diseases. Then, by using targeted methods such as PCR (a technique to make multiple copies of a fragment of DNA), the results can be verified and adjusted. According to the researchers, the program could greatly reduce the time needed to develop new drugs.
Microorganisms that do not reproduce in vitro, such as viruses, give very abstract results in tests and it is not possible to collect their DNA. However, the new program is able to detect even these microorganisms. “In the microbiota of the skin alone, 90% of the organisms are unknown,” continues Dmitry Alexeev. “Our approach enables us to work with completely unknown material and still obtain results. The program has been tested in a wide variety of environments, including those with a high number of viruses. The program is even able to locate and collect single DNA strands.”
MetaFast is not limited to detecting pathogens. For example, the program canalso be used to compare distinct peoples in closed populations with people living in cities to help identify bacterial strains that are extremely useful to humans, but have been lost in the process of urbanization. Antibiotics, preservatives, colorants and supermarket food have pushedmany useful bacteria out of our microflora, but these bacteria could still be present in closed populations, such as American Indians or people in Russian villages.
MetaFast has proven to be highly effective in studying rare and undiscovered metagenomes. As a part of the study, the scientists analysed the metagenome of several of the world’s largest lakes. Without any information about the samples of microbiota from the lakes, the program found genetic similarities between samples that were close in terms of their chemical composition.
The researchers also used the new algorithm to study the inhabitants of the New York underground, demonstrating the effectiveness of the algorithm when analysing such complex systems. Most of the DNA collectedusing MetaFast belonged to already known bacteria. This confirms previous theories stating that the subway is safe for humans, and the microbes that live there suppress any flora that could be dangerous to people.
A vast amount of experimental data has already been gathered worldwide on various metagenomes. As the cost of extracting DNA is decreasing and the sensitivity of equipment is increasing, the volume of data is continuing to grow exponentially. Despite this, most of the studies have not been fully completed. The reason lies in the limitations of the current technology. On the one hand, scientists are able to partially collect a metagenome, but piecing together the “puzzle” takes an enormous amount of time. On the other hand, they can compare individual fragmentsof the genome with existing DNA references, but there are very limited numbers of bacteria, and virtually no viruses.
The new algorithm not only combines the advantages of both of these approaches, but also enables data to be processed at high speed. The program saves RAM because it partially collects and partially compares genomes, but does not go into an in-depth collection analysis.
Learn more:Â Personalized medicine will employ computer algorithms
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- 3D model of brain tumor environment could aid personalized treatmenton August 1, 2022 at 3:06 pm
Virginia Tech scientists at the Fralin Biomedical Research Institute at VTC have developed a novel 3D tissue-engineered model of the glioblastoma tumor microenvironment that can be used to learn why ...
- Proposal by research team could revolutionize space medicine, improve astronaut healthon August 1, 2022 at 8:10 am
Often when researching the molecular and biological changes that happen in space, models such as rodents, worms, and yeast are used to study the effects and consequences of long-duration space flight ...
- OMNI scientist Szewczyk collaborates on proposal that could revolutionize space medicine, improve astronaut healthon July 29, 2022 at 10:28 pm
Nate Szewczyk and several other researchers from around the world have published a paper that proposes a program for the European Space Agency that could potentially revolutionize space medicine.
- Personalized Medicine Market Size Worth $796.8 Billion by 2028 - Grand View Research, Inc.on July 21, 2022 at 5:30 am
Personalized medicines focus on patients' medical history, diagnosis, and disease conditions to provide effective treatment and care. Precision medicine, P4 medicine, personalized medicine, and ...
- Global precision medicine market is projected to grow at a CAGR of 10.8% by 2032: Visiongain Reports Ltdon July 21, 2022 at 1:39 am
Visiongain has published a new report entitled Precision Medicine 2022-2032. It includes profiles of precision medicine and Forecasts Market Segment by Product Type (Diagnostics, {Genetic tests, ...
- Worms as a model for personalized medicineon July 19, 2022 at 10:42 pm
Tailoring a person's diet or medicine based on their genomes has been a goal of the medical community for decades, but the strategy has not been widely successful because people metabolize chemicals ...
- Deep phenotyping brings accuracy to precision medicineon July 18, 2022 at 12:42 am
Biotech companies are leveraging the wealth of omics and imaging data to study deep phenotypes for a range of clinical applications including precision medicine approaches to liver disease, ...
- Kenya could Implement Personalized Medicine in the Next Five Yearson July 15, 2022 at 7:08 pm
Kenya has the potential to implement personalized medicine- a medical model that is used to determine the genetic makeup of a person in order to know the best drug that is specifically suitable ...
- Personalized Medicine and Epigenomics Market SWOT Analysis By 2028 | Size, Scope, Top Companies, Growth Drivers By VMRon July 12, 2022 at 7:50 am
Jul 12, 2022 (Heraldkeepers) -- New Jersey, United States,- The Global Personalized Medicine and Epigenomics Market research includes an in-depth analysis of key geographical trends, market ...
- Worms as model for personalized medicineon July 11, 2022 at 2:02 pm
This advancement represents a potentially important step toward 'personalized' or 'precision' medicine, a relatively new discipline that tailors dietary advice and disease treatment to an ...
via Bing News